To validate this view, in the current study we investigated whether type 2 diabetic patients have increased plasma CTSD activity compared to healthy individuals and whether plasma CTSD levels and activity link to postprandial metabolic parameters of type 2 diabetes. This evidence concerns the gene CTSD and type 2 diabetes mellitus.